Allendale, NJ, 29 October 2014 – On 12 September 2014, the U.S. Centers for Disease Control and Prevention (CDC) issued an official health advisory titled, “Severe Respiratory Illness Associated with Enterovirus D68 – Multiple States, 2014” stating1*
- As EV-D68 is a non-enveloped virus, environmental disinfection of surfaces in healthcare settings should be performed using a hospital-grade disinfectant with an EPA label claim for any of several non-enveloped viruses (e.g. norovirus, poliovirus, rhinovirus). Disinfectant products should be used in accordance with the manufacturer’s instructions for the specific label claim and in a manner consistent with environmental infection control recommendations.
Lonza is a leading global manufacturer of disinfectants and disinfectant cleaners, many with supported label claims for viruses including those identified by the CDC. “Available within Lonza’s U.S. portfolio are several product families that meet the CDC guidance concerning efficacy against non-enveloped viruses, including Bardac® 205M, Lonzagard® HWS, Lonzagard® R-82, Lonzagard® Disinfectant Wipes and the Lonzagard® RCS™ family.” said Michael DeGennaro, Lonza’s NAFTA Vice President of Consumer Care.